Assignee
SHANGHAI JUNCELL THERAPEUTICS CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
5 records- 0160US2025049920A1Membrane surface protein containing gpi anchor regionSHANGHAI JUNCELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0253US2024238271A1Pharmaceutical composition for enhancing cell killing, and use thereofSHANGHAI JUNCELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0353US2024325538A1Tumor infiltration lymphocyte culture medium and application thereofSHANGHAI JUNCELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0451US2023383268A1Novel piggybac transposon system and use thereofSHANGHAI JUNCELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0550US2023226111A1Seed cell medium of tumor-infiltrating lymphocyte and application thereofSHANGHAI JUNCELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI JUNCELL THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →